Global fundamental equity investment manager based in San Francisco, with offices in New York, West Palm Beach and London. Its industry specialists cover biotechnology, medical devices, AI infrastructure, semiconductors and other sectors. Alongside public equity strategies, it participates in private company and negotiated public company financings, including companies developing treatments for neurodegenerative and mental health disorders.